Ubiquitin proteasome system regulation of synaptic function

泛素蛋白酶体系统对突触功能的调节

基本信息

  • 批准号:
    7221878
  • 负责人:
  • 金额:
    $ 16.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-15 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The applicant is a physician scientist who has completed a neurology residency and a clinical epilepsy fellowship and is a recently appointed tenure-track Assistant Professor in the Vanderbilt University Neurology Department. The five year support from a Mentored Career Development Award (K08) would be used by the applicant to become established as an independent investigator working as a synaptic physiologist with the goal of understanding molecular mechanisms of epileptogenesis and neurodegeneration. This proposal focuses on understanding the role of the ubiquitin proteasome system (UPS) in regulating glutamatergic synaptic transmission, using the Drosophila neuromuscular junction (NMJ) and cultured hippocampal neurons as model synaptic systems. The covalent addition of the small protein, ubiquitin, targets proteins for intracellular trafficking and degradation by the proteasome. Recently, the UPS has been demonstrated to function locally at the synapse and regulate synaptic plasticity, but the mechanistic details about the specific ubiquitin ligases, protein targets, and the time scale over which the regulation occurs have just begun to be addressed. Preliminary data from the Drosophila NMJ suggests that the UPS regulates the abundance of the key postsynaptic density organizing protein, discs large, and also regulates a retrograde signaling pathway important for maintaining homeostatic synaptic plasticity. Understanding the mechanisms of UPS regulation of these fundamental synaptic pathways will likely have widespread implications for understanding the physiological changes in synaptic strength that occur during learning and memory as well as pathological changes that occur in epilepsy and neurodegenerative diseases. The proposed research will be performed under the guidance of Dr. Kendal Broadie, Stevenson Professor of Neurobiology, and Dr. Robert Macdonald, Chair of the Vanderbilt Neurology Department, who has a distinguished record of training physician scientists investigating basic mechanisms of epilepsy. Understanding the mechanisms of long-term synaptic changes that occur in epilepsy and neurodegenerative diseases is fundamental to developing new and better treatments for these diseases. Given the large complement of UPS regulatory proteins encoded in the genome, identifying specific synaptic UPS pathways offers the hope of developing targeted interventions for prevention and treatment of these diseases.
描述(由申请人提供):申请人是一名医生科学家,已完成神经病学住院医师和临床癫痫奖学金,最近被任命为范德比尔特大学神经病学系的终身助理教授。来自辅导职业发展奖(K08)的五年支持将被申请人用来成为一名独立的研究者,作为一名突触生理学家,以了解癫痫发生和神经退行性变的分子机制为目标。本研究以果蝇神经肌肉接头(NMJ)和培养的海马神经元为模型突触系统,探讨泛素蛋白酶体系统(UPS)在调节神经元能突触传递中的作用。共价添加的小蛋白,泛素,靶向蛋白质的细胞内运输和降解的蛋白酶体。最近,UPS已被证明在突触局部发挥作用,并调节突触可塑性,但有关特定的泛素连接酶,蛋白质靶点和调节发生的时间尺度的机制细节刚刚开始得到解决。来自果蝇NMJ的初步数据表明,UPS调节关键突触后密度组织蛋白的丰度,盘大,并且还调节对维持稳态突触可塑性重要的逆行信号通路。了解这些基本突触通路的UPS调节机制可能对理解学习和记忆过程中发生的突触强度的生理变化以及癫痫和神经退行性疾病中发生的病理变化具有广泛的意义。拟议的研究将在史蒂文森神经生物学教授肯达尔布罗迪博士和范德比尔特神经病学系主任罗伯特麦克唐纳博士的指导下进行,他在培训医生科学家研究癫痫的基本机制方面有着杰出的记录。了解癫痫和神经退行性疾病中发生的长期突触变化的机制对于开发这些疾病的新的和更好的治疗方法至关重要。鉴于基因组中编码的UPS调节蛋白的大量补充,识别特定的突触UPS通路为开发预防和治疗这些疾病的靶向干预提供了希望。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN F HAAS其他文献

KEVIN F HAAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN F HAAS', 18)}}的其他基金

Ubiquitin proteasome system regulation of synaptic function
泛素蛋白酶体系统对突触功能的调节
  • 批准号:
    7394994
  • 财政年份:
    2006
  • 资助金额:
    $ 16.52万
  • 项目类别:
Ubiquitin proteasome system regulation of synaptic function
泛素蛋白酶体系统对突触功能的调节
  • 批准号:
    7586703
  • 财政年份:
    2006
  • 资助金额:
    $ 16.52万
  • 项目类别:
Ubiquitin proteasome sytem regulation of synaptic fuction
泛素蛋白酶体系统对突触功能的调节
  • 批准号:
    7095447
  • 财政年份:
    2006
  • 资助金额:
    $ 16.52万
  • 项目类别:
Ubiquitin proteasome system regulation of synaptic function
泛素蛋白酶体系统对突触功能的调节
  • 批准号:
    7799118
  • 财政年份:
    2006
  • 资助金额:
    $ 16.52万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 16.52万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 16.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了